A Randomized, Multi-Center, Double-Blind, Factorial, Comparator and Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains.

Trial Profile

A Randomized, Multi-Center, Double-Blind, Factorial, Comparator and Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Dec 2015

At a glance

  • Drugs Etodolac; Etodolac/lidocaine; Lidocaine
  • Indications Musculoskeletal pain; Sprains
  • Focus Therapeutic Use
  • Sponsors MEDRx
  • Most Recent Events

    • 14 Nov 2011 Actual end date (June 2011) added as reported by ClinicalTrials.gov.
    • 14 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top